Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOP UP Trial: Supplemental Parenteral Nutrition in Critically Ill Patients
NCT01206166Phase 3Terminated
- Sponsor
- Kingston General Hospital
- Start
- Jun 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of l-leucine in critical illness, acute respiratory failure (ARF), sponsored by Kingston General Hospital. Started Jun 2011; status: terminated.
02
Drugs
l-leucine
03
Conditions
critical illnessacute respiratory failure (ARF)
Beyond the preview
Go deeper on NCT01206166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01206166.